Authors:
SANNER MA
CHAPPIE TA
DUNAISKIS AR
FLIRI AF
DESAI KA
ZORN SH
JACKSON ER
JOHNSON CG
MORRONE JM
SEYMOUR PA
MAJCHRZAK MJ
FARACI WS
COLLINS JL
DUIGNAN DB
DIPRETE CC
LEE JS
TROZZI A
Citation: Ma. Sanner et al., SYNTHESIS, SAR AND PHARMACOLOGY OF CP-293,019 - A POTENT, SELECTIVE DOPAMINE D-4 RECEPTOR ANTAGONIST, Bioorganic & medicinal chemistry letters, 8(7), 1998, pp. 725-730
Citation: Er. Jackson, SCOTLAND AFTER ENLIGHTENMENT - IMAGE AND TRADITION IN MODERN SCOTTISHCULTURE - BEVERIDGE,C, TURNBULL,R, Textual practice, 12(1), 1998, pp. 127-131
Authors:
SCHMIDT AW
FOX CB
JACKSON ER
LAZZARO J
MCLEAN S
GANONG A
ZORN SH
SCHULZ DW
DESAI K
BRIGHT GM
HEYM J
Citation: Aw. Schmidt et al., CP-93,393 - IN-VITRO CHARACTERIZATION OF A NOVEL ANXIOLYTIC ANTIDEPRESSANT AGENT WITH BOTH 5-HT1A AGONIST AND ALPHA-2-ADRENERGIC ANTAGONISTPROPERTIES/, Journal of neurochemistry, 66, 1996, pp. 38-38
Citation: Er. Jackson, THE PROPER USE AND BENEFITS OF VETERINARY ANTIMICROBIAL AGENTS IN PRACTICE IN CATTLE, Veterinary microbiology, 35(3-4), 1993, pp. 349-356
Citation: Kl. Wiese et Er. Jackson, CHANGES IN THERMAL-PROCESS TIMES (B(B)) FOR BAKED BEANS BASED ON WATER HARDNESS AND FILL TEMPERATURE, Journal of food protection, 56(7), 1993, pp. 608-611
Authors:
LOWE JA
DROZDA SE
SNIDER RM
LONGO KP
ZORN SH
JACKSON ER
MORRONE J
MCLEAN S
BRYCE DK
BORDNER J
NAGAHISA A
KANAI Y
SUGA O
TSUCHIYA M
Citation: Ja. Lowe et al., DISCOVERY OF CP-96,345 AND ITS CHARACTERIZATION IN DISEASE-MODELS INVOLVING SUBSTANCE-P, Regulatory peptides, 46(1-2), 1993, pp. 20-23
Authors:
SNIDER RM
LONGO KP
ZORN SH
MORRONE J
JACKSON ER
NAGAHISA A
KANAI Y
SUGA O
NAKAGAKI M
DROZDA SE
LOWE JA
Citation: Rm. Snider et al., DIFFERENTIAL SAR OF QUINUCLIDINE SP ANTAGONISTS BETWEEN RAT AND HUMAN-TYPE RECEPTORS, Regulatory peptides, 46(1-2), 1993, pp. 290-292